3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
21
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
7
Skin Neoplasms
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Colorectal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Uveal Melanoma
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pleural Effusion, Malignant
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Interventions
Radiotherapy
2
Paclitaxel
2
Carboplatin
2
talimogene laherparepvec
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Trastuzumab
1
Taxes
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Radiation
1
Mastectomy, Segmental
1
Mastectomy
1
Mass Spectrometry
1
Immunohistochemistry
1
Gene Expression Profiling
1
Fulvestrant
1
Fluorescent Antibody Technique
1
Doxorubicin
1
Docetaxel
1
Cyclophosphamide
1
Counseling
1
Chromatography, Liquid
1
Brachytherapy
1
Anastrozole
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ductal, Breast
×
Interleukin-2
×
1 year
×
Clear all
No trials found.